These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16648264)

  • 1. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.
    Wu X; Anderson JL; Campbell EM; Joseph AM; Hope TJ
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7465-70. PubMed ID: 16648264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
    Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
    J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
    Campbell EM; Perez O; Anderson JL; Hope TJ
    J Cell Biol; 2008 Feb; 180(3):549-61. PubMed ID: 18250195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infection.
    Danielson CM; Cianci GC; Hope TJ
    Traffic; 2012 Sep; 13(9):1206-17. PubMed ID: 22624877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.
    Campbell EM; Weingart J; Sette P; Opp S; Sastri J; O'Connor SK; Talley S; Diaz-Griffero F; Hirsch V; Bouamr F
    J Virol; 2016 Feb; 90(4):1849-57. PubMed ID: 26676782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
    Soll SJ; Wilson SJ; Kutluay SB; Hatziioannou T; Bieniasz PD
    PLoS Pathog; 2013; 9(9):e1003667. PubMed ID: 24086139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
    Kutluay SB; Perez-Caballero D; Bieniasz PD
    PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
    Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
    J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production.
    Sukegawa S; Sakuma R; Ohmine S; Takeuchi H; Ikeda Y; Yamaoka S
    PLoS One; 2014; 9(10):e109640. PubMed ID: 25310711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5α.
    Morger D; Zosel F; Bühlmann M; Züger S; Mittelviefhaus M; Schuler B; Luban J; Grütter MG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction.
    Lukic Z; Goff SP; Campbell EM; Arriagada G
    Retrovirology; 2013 Feb; 10():10. PubMed ID: 23369348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction of HIV-1 by rhesus TRIM5α is governed by alpha helices in the Linker2 region.
    Sastri J; Johnsen L; Smolin N; Imam S; Mukherjee S; Lukic Z; Brandariz-Nuñez A; Robia SL; Diaz-Griffero F; Wiethoff C; Campbell EM
    J Virol; 2014 Aug; 88(16):8911-23. PubMed ID: 24872590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
    Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
    Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions.
    Lukic Z; Hausmann S; Sebastian S; Rucci J; Sastri J; Robia SL; Luban J; Campbell EM
    Retrovirology; 2011 Nov; 8():93. PubMed ID: 22078707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilized human TRIM5α protects human T cells from HIV-1 infection.
    Richardson MW; Guo L; Xin F; Yang X; Riley JL
    Mol Ther; 2014 Jun; 22(6):1084-1095. PubMed ID: 24662946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.
    Perez-Caballero D; Hatziioannou T; Zhang F; Cowan S; Bieniasz PD
    J Virol; 2005 Dec; 79(24):15567-72. PubMed ID: 16306627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.
    Richardson MW; Carroll RG; Stremlau M; Korokhov N; Humeau LM; Silvestri G; Sodroski J; Riley JL
    J Virol; 2008 Nov; 82(22):11117-28. PubMed ID: 18768965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.